Clinical utility of androgen-receptor splice variant 7 (AR-V7) determinations in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).

Piana, D; Luo, J; Markowski, MC; Shenderov, E; Antonarakis, ES; Eisenberger, MA

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (15):